Nektar Therapeutics Falling Today on Above-Average Volume (NKTR)
Nektar Therapeutics's stock is down 5.2% to $13.35 on heavy trading volume. Approximately 2.9 million shares have changed hands today vs. average 30-day volume of 1.1 million shares. Unusually high volume can signify a potential turning point or validate a breakout.
SmarTrend recommended that its subscribers protect gains by selling shares of Nektar Therapeutics on September 27th, 2016 by issuing a Downtrend alert when the shares were trading at $17.32. Since that call, shares of Nektar Therapeutics have fallen 18.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
Over the past year, Nektar Therapeutics has traded in a range of $9.16 to $19.98 and is now at $13.35, 46% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.1% while the 200-day MA has risen 0.3%.
Keywords: unusual volume nektar therapeutics